Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Sep 14;47(5):665-6.
doi: 10.1016/j.molcel.2012.08.020.

DNA mismatch repair: Dr. Jekyll and Mr. Hyde?

Affiliations
Comment

DNA mismatch repair: Dr. Jekyll and Mr. Hyde?

Peggy Hsieh. Mol Cell. .

Abstract

In this issue, Peña-Diaz et al. (2012) describe a pathway for somatic mutation in nonlymphoid cells termed noncanonical DNA mismatch repair, whereby the error-prone translesion polymerase Pol-η substitutes for high-fidelity replicative polymerases to resynthesize excised regions opposite DNA damage.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Mutagenic and Nonmutagenic Outcomes of DNA Mismatch Repair
(A) General scheme for replication-linked MMR in which recognition of a mismatch by a MutSα-MutLα complex modulated by interaction with PCNA and ATP/ADP binding by MMR proteins licenses excision of the newly synthesized strand by EXO1 and an endonuclease function in the PMS2 subunit of MutLα. The resulting RPA-coated single-strand gap is a substrate for resynthesis by high-fidelity Pol-δ. (B) In activated B cells, AID creates G/U mispairs that are substrates for MutSα-MutLα. An ncMMR pathway is utilized in which mUbPCNA recruits Pol-η to carry out error-prone gap filling to achieve somatic hypermutation at variable regions of Ig genes. (C) A scenario for a ncMMR pathway operating in nonlymphoid cells that responds to a variety of DNA lesions that are substrates for MutSα including uracil, alkylated bases, and distorted DNA structures that impede replication. Recruitment of Pol-η by monoubiquitinated PCNA leads to error-prone gap filling.

Comment on

References

    1. Chahwan R, Edelmann W, Scharff MD, Roa S. Semin. Immunol. 2012;24:293–300. - PMC - PubMed
    1. Hombauer H, Campbell CS, Smith CE, Desai A, Kolodner RD. Cell. 2011;147:1040–1053. - PMC - PubMed
    1. Hsieh P, Yamane K. Mech. Ageing Dev. 2008;129:391–407. - PMC - PubMed
    1. Karran P, Attard N. Nat. Rev. Cancer. 2008;8:24–36. - PubMed
    1. Kunkel TA, Erie DA. Annu. Rev. Biochem. 2005;74:681–710. - PubMed

LinkOut - more resources